Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

31 Mar 2026 07:00

RNS Number : 5254Y
Ebiquity PLC
31 March 2026
 

31 March 2026

Ebiquity Plc

("the Company" or "Ebiquity")

 

Total Voting Rights

 

Ebiquity plc, the independent authority in marketing effectiveness, notifies that, as of 31 March 2026, the Company's share capital consists of 141,215,531 ordinary shares of 25 pence each ("Ordinary Shares"), with each Ordinary Share carrying the right to one vote.

 

The Ebiquity plc Employee Benefit Trust holds 2,262,845 Ordinary Shares to satisfy awards under the Company's share option plans. The trustee of the EBT has agreed not to vote Ordinary Shares held by it such that these Ordinary Shares are treated as not carrying voting rights.

 

The total voting rights in the Company are therefore 138,952,686. This figure may be used by shareholders as the denominator for calculations to determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Ebiquity plc

Dorcas Murray, Company Secretary

 +44 (0) 20 7650 9600

 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson/ Andrea Callaghan - Corporate Finance

 +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

 

About Ebiquity plc

 

Ebiquity is the independent authority in Marketing Effectiveness. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by over 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

For further information, please visit: www.ebiquity.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUBSBRNKUOUAR
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.